Key result
SES linked to delayed neointimal coverage and slower thrombus disappearance vs BMS at 6 months.
Why the study?
The differences in neointimal coverage and intracoronary thrombus persistence between sirolimus-eluting stents and bare metal stents at 6 months after implantation were unclear.
Do sirolimus-eluting stents delay neointimal coverage and increase thrombus persistence compared to bare metal stents in patients with coronary artery disease?
Observational (n=46)
Do sirolimus-eluting stents delay neointimal coverage and increase thrombus persistence compared to bare metal stents in patients with coronary artery disease?
Sirolimus-eluting stents demonstrate delayed neointimal coverage and slower thrombus resolution compared to bare metal stents at 6 months post-implantation, as visualized by angioscopy.
Raises concern for late stent thrombosis with SES; leaves open optimal DAPT duration pending larger trials.
AIMS: The neointimal coverage and intracoronary thrombi within stented segments at 6 months after implantation between sirolimus-eluting stents (SESs) and bare metal stents (BMSs) were compared by direct visualization using angioscopy. METHODS AND RESULTS: Forty-six patients (36 stable angina and 10 acute coronary syndrome) were treated with 33 SESs and 33 BMSs. Immediately after and 6 months after stenting, each of the stented segments, edge body, and overlapping segment were observed by angioscopy and the grade of neointimal coverage over the stents was classified as 0: absent neointima, 1: visible struts through thin neointima, or 2: invisible struts. The existence of thrombi was also evaluated. The average grade of the neointimal coverage at 6 months follow-up was lower in the SES than that in the BMS (edge: 1.4+/-0.7 vs. 1.9+/-0.2, body: 1.0+/-0.5 vs. 1.8+/-0.5, overlapping segment: 0.6+/-0.7 vs. 1.8+/-0.5; P<0.0001, P<0.0001, P=0.0069, respectively). The frequency of persistence of thrombus was significantly higher in the SESs than that in the BMSs (86 vs. 29%, respectively; P=0.031). CONCLUSION: The present study suggested a delayed neointimal stent coverage and slower thrombus disappearance process in the SESs in comparison to the BMSs.
No takes yet. Share an insight, caveat, or question.
Makoto Takano (2006) conducted an observational in Stable angina and acute coronary syndrome (n=46). Sirolimus-eluting stents (SESs) vs. Bare metal stents (BMSs) was evaluated on Persistence of thrombus (p=0.031). Sirolimus-eluting stents had a significantly higher frequency of persistent thrombus at 6 months compared to bare metal stents (86% vs. 29%; P=0.031).
Synapse has enriched 5 related papers. Consider them for comparative context: